23
Nov
2026
IICC, Yashobhoomi, Dwarka, Delhi
23 Nov 2026 - 25 Nov 2026
stand IP-22

J P N PHARMA PRIVATE LIMITED

About J P N PHARMA PRIVATE LIMITED

Established in 1988 with a plant at Tarapur, India. Manufacturer of Active Pharma Ingredients and Drug Intermediates. WHO GMP certified (Certificate No. NEW-WHO-GMP/CERT/KD/17069/2014/11/6976) Written Confirmation Certified (Certificate No. WC-0336)

Meet us at

  • CPHI India 2026

    IICC, Yashobhoomi, Dwarka, Delhi
    23 Nov 2026 - 25 Nov 2026
    stand IP-22
  • Country/Region:
    India
  • On CPHI since:
    2015
Contact info
  • Office No. 1, 1st Floor ,Arihant Enclave, Ashok Nagar,Ashok Chakravarti Road,, Kandivali, 400101, Mumbai, India

Products from J P N PHARMA PRIVATE LIMITED (26)

  • Allopurinol

    Product Allopurinol

    Antigout Bulk Drug 
  • Phenobarbital

    Product Phenobarbital

    Anticonvulsant Bulk Drug 
  • Eplerenone

    Product Eplerenone

    Antihypertensive Bulk Drug
  • Alendronate Sodium / Alendronic Acid

    Product Alendronate Sodium / Alendronic Acid

    High-quality API for the treatment and prevention of osteoporosis and other bone-related disorders.
  • Bisacodyl

    Product Bisacodyl

    API used as a stimulant laxative for the treatment of occasional constipation.
  • Fosphenytoin Sodium

    Product Fosphenytoin Sodium

    Water-soluble prodrug of phenytoin used primarily for the management of seizures and status epilepticus.
  • Glyccopyrollate

    Product Glyccopyrollate

    Anticholinergic API used to reduce excessive secretions and in various applications requiring inhibition of muscarinic activity.
  • Ibandronate Sodium/ Acid

    Product Ibandronate Sodium/ Acid

    Bisphosphonate API used for the prevention and treatment of osteoporosis and related bone disorders.
  • Memantine HCl

    Product Memantine HCl

    NMDA receptor antagonist API used in the treatment of moderate to severe Alzheimer's disease.
  • Palonosetron HCl

    Product Palonosetron HCl

    5-HT3 receptor antagonist API used for the prevention of chemotherapy-induced nausea and vomiting and postoperative nausea and vomiting.